Case report: Daratumumab treatment in pre-transplant alloimmunization and severe hemolytic anemia

Overview of attention for article published in Frontiers in immunology, November 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 4 X users

Readers on

mendeley: 9 Mendeley

Summary X

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 56,930 followers.

Case report: Daratumumab treatment in pre-transplant alloimmunization and severe hemolytic anemia https://t.co/8wWzIQipU3 https://t.co/gDU8uK9Ylz

02 Dec 2022

Reply Repost Favourite

New Research: Case report: Daratumumab treatment in pre-transplant alloimmunization and severe hemolytic anemia: Daratumumab, a CD38 monoclonal antibody that has been FDA-approved to treat multiple myeloma, has acquired popularity and is used… https://t.co

29 Nov 2022

Reply Repost Favourite

RT @GarbineLizeaga: Case report: Daratumumab treatment in pre-transplant alloimmunization and severe hemolytic anemia https://t.co/yW4ZfXVe…

29 Nov 2022

Reply Repost Favourite

Case report: Daratumumab treatment in pre-transplant alloimmunization and severe hemolytic anemia https://t.co/yW4ZfXVeD7

29 Nov 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.